David Liu, Ph.D.


Dr. Liu joins the firm as a biotech Analyst. Prior to joining Iguana, David was a Research Associate at RBC Capital Markets covering small and mid-cap biotech. With over 8 years of scientific research experience, David brings to the firm an extensive scientific background, with a particular focus on oncology. David received his B.S. with Honors in Biological Sciences from Stanford University and a Ph.D. in Molecular Biology from Cornell University.